Back to all webinars
Latest insights on IO treatment of resectable NSCLC
Luis Paz-Ares and Federico Cappuzzo share their insights on optimal timing for IO treatment in resectable NSCLC and reflect on key data presented at WCLC and ESMO 2024.
Speakers
The latest evidence supporting the use of IO in resectable NSCLC
No entries
Key treatment considerations: PD-L1 expression status and disease Stage
No entries
Optimizing IO treatment approaches
No entries
Assessing the risk of delaying surgery
No entries
Unanswered questions and future treatments for resectable NSCLC
No entries
Final thoughts
No entries